Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc. scores highest on Torque (70) and lowest on Earnings (38). Its PosiPenta is 51.12 out of 100, around the middle of similar companies.
On the Penta Grid this week, Whitehawk Therapeutics, Inc. is Grid #270 of 837 in the Healthcare sector in United States, and Grid #1,748 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. | 51.12 | 40 | 38 | 53 | 70 | 54 |
| Entrada Therapeutics, Inc. | 35.49 | 43 | 28 | 23 | 44 | 39 |
| PepGen Inc. | 35.04 | 33 | 35 | 38 | 42 | 27 |
| Inogen, Inc. | 54.59 | 40 | 61 | 64 | 61 | 47 |
| Eledon Pharmaceuticals, Inc. | 38.77 | 13 | 42 | 47 | 52 | 40 |
| Precision BioSciences, Inc. | 35.69 | 19 | 27 | 62 | 25 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.54 |
| P/B ratio | 0.90 |
EEarnings
| Trailing EPS | ₹-107.97 |
| Forward EPS | ₹-93.53 |
NNitro
| Price | 273.73 |
| 52-week high | 520.46 |
| 52-week low | 186.59 |
| Fall from 52-week high | 47.4% |
TTorque
| Return on equity (ROE) | -44.98% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.91 |
| Market cap | ₹1,560 Cr |
| Insider holding | 12.62% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Whitehawk Therapeutics, Inc.'s PosiPenta score?
Whitehawk Therapeutics, Inc.'s PosiPenta is 51.12 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Whitehawk Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Whitehawk Therapeutics, Inc. is Grid #270 of 837 in the Healthcare sector in United States, and Grid #1,748 of 4,000 in United States.
Which PosiPenta pillar is strongest for Whitehawk Therapeutics, Inc.?
Torque (durability), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Whitehawk Therapeutics, Inc.?
Earnings (growth), with a score of 38 out of 100: weaker than most similar companies.
Has Whitehawk Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.13 points, from 47.99 to 51.12.
PositoAI is for research and education only and is not investment advice.